2-oxoadipate dehydrogenase L-lysine degradative pathway 2-oxoadipate dehydrogenase complex assembly with hE2o and hE3 Glutaryl-CoA ThDP-enamine radical Superoxide and H 2 O 2 generation α-ketol carboligation product A B S T R A C T Herein are reported unique properties of the novel human thiamin diphosphate (ThDP)-dependent enzyme 2-oxoadipate dehydrogenase (hE1a), known as dehydrogenase E1 and transketolase domain-containing protein 1 that is encoded by the DHTKD1 gene. It is involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA on the final degradative pathway of L-lysine and is critical for mitochondrial metabolism. Functionally active recombinant hE1a has been produced according to both kinetic and spectroscopic criteria in our toolbox leading to the following conclusions: (i) The hE1a has recruited the dihydrolipoyl succinyltransferase (hE2o) and the dihydrolipoyl dehydrogenase (hE3) components of the tricarboxylic acid cycle 2-oxoglutarate dehydrogenase complex (OGDHc) for its activity. (ii) 2-Oxoglutarate (OG) and 2-oxoadipate (OA) could be oxidized by hE1a, however, hE1a displays an approximately 49-fold preference in catalytic efficiency for OA over OG, indicating that hE1a is specific to the 2-oxoadipate dehydrogenase complex. (iii) The hE1a forms the ThDP-enamine radical from OA according to electron paramagnetic resonance detection in the oxidative half reaction, and could produce superoxide and H 2 O 2 from decarboxylation of OA in the forward physiological direction, as also seen with the 2-oxoglutarate dehydrogenase hE1o component. (iv) Once assembled to complex with the same hE2o and hE3 components, the hE1o and hE1a display strikingly different regulation: both succinyl-CoA and glutaryl-CoA significantly reduced the hE1o activity, but not the activity of hE1a.
Introduction
The human thiamin diphosphate (ThDP)-dependent 2-oxoadipate dehydrogenase (hE1a), also known as dehydrogenase E1 and transketolase domain-containing protein 1 (DHTKD1), is believed to be involved in the oxidative decarboxylation of 2-oxoadipate (OA) to glutaryl-CoA, a product on the final degradative pathway of L-lysine, Lhydroxylysine and L-tryptophan [1] [2] [3] [4] [5] [6] [7] . The glutaryl-CoA so formed serves as a substrate for glutaryl-CoA dehydrogenase (GCDH: EC 1.3.99.7), which is located downstream of hE1a on the L-lysine degradative pathway and produces glutaconyl-CoA, the precursor for acetyl-CoA [8] . Glutaryl-CoA also serves as a precursor for neurotoxic metabolites such as glutaric acid and 3-hydroxyglutaric acid, which accumulate in glutaric aciduria type I, a metabolic disorder related to GCDH deficiency [9] [10] [11] . Recently, mutations were identified in the DHTKD1 gene that cause 2-aminoadipic and 2-oxoadipic aciduria, inborn disorders which have been associated with various neurological symptoms [2, 3, 5, 6] . The suppression of DHTKD1 in mitochondria led to a decreased level of ATP and reduced 2-oxoglutarate dehydrogenase complex (OGDHc) activity, as well as to an increased production of reactive oxygen species, suggesting that the DHTKD1 encoded protein is essential for mitochondrial metabolism [4] . The pharmacological inhibition of the DHTKD1 was suggested as a promising strategy to treat glutaric aciduria type I [10] . However, the suppression of DHTKD1 in Dhtkd1-/Gcdh-double knockout mice did not rescue the clinical and biochemical phenotype of glutaric aciduria I, suggesting that an alternative route via the OGDHc may at least partially substitute for the loss of DHTKD1 function [10] . This hypothesis is in agreement with findings reported by our group recently, which suggested that hOGDHc behaves as a 2-oxoadipate dehydrogenase, in addition to its 2-oxoglutarate dehydrogenase activity in the tricarboxylic acid cycle (TCA) [12] . At present, no studies on the hE1a are available from any source in the literature. Nor is there any information available about the presence of a specific dihydrolipoamide glutaryltransferase component that would suggest that the hE1a is the first component of a novel 2-oxoadipate dehydrogenase complex [13] , or evidence for OGDHc-like hybrid complex formation with function via the TCA.
In view of the above information, it was of importance to express recombinant hE1a and to characterize its function using the numerous independent experiments developed in our toolbox for the study of the superfamily of 2-oxo acid dehydrogenase complexes [12, 14] . These studies were made possible by our successful expression of the hE1a component, and of the individual components of hOGDHc: the ThDPdependent 2-oxoglutarate dehydrogenase (hE1o; EC1.2.4.2), dihydrolipoyl transsuccinylase (hE2o; EC 2.3.1.61) and dihydrolipoyl dehydrogenase (hE3; EC1.8.1.4; the E3 component is common to all such complexes in a particular cell) (Scheme 1) [15] [16] [17] [18] . The important conclusion from current studies is that the hE1a and the hE1o components could each assemble with the same hE2o and E3 components into the corresponding complexes; they are not functionally redundant, and they both could contribute to the pathologies associated with neurodegenerative disorders, especially those related to oxidative stress in the mitochondria.
Material and methods

Reagents
ThDP, NAD + , CoA, DTT, D,L-α lipoic acid, IPTG, thiamin·HCl, imidazole, DNase I and Micrococcal Nuclease were from Affymetrix; catalase from bovine liver, hydrogen peroxide, peroxidase from horseradish, superoxide dismutase, 2-oxoglutaric acid, 2-oxoadipic acid, 3-methyl-2-oxovaleric acid sodium salt, benzamidine·HCl, glutaryl-CoA lithium salt and succinyl-CoA were from Sigma-Aldrich; Amplex™
UltraRed was from Invitrogen via Thermo Fisher Scientific; Ni Sepharose High Performance was from GE Healthcare.
Protein expression and purification
Expression and purification of hE1o, hE2o, hE2o catalytic domain (CDo), and hE3 was as reported earlier [19] . Expression and purification of E2o lipoyl domain (LDo) and its lipoylation in vitro by E. coli lipoyl protein ligase, was as reported earlier [19] .
Construction of plasmid and expression and purification of hE1a
The gene encoding C-terminally His 6 -tagged hE1a was synthesized by ATUM (www.atum.bio Newark, CA). The DHTKD1 codon optimized for expression in E. coli cells was inserted into pET-22b (+) vector through the NdeI and XhoI restriction sites, and the resulting plasmid was expressed in BL21(DE3) cells. Cells were grown in LB medium supplemented with 50 μg/ml ampicillin containing 1 mM MgCl 2 and 0.50 mM thiamin·HCl. Protein expression was induced by 0.5 mM IPTG for 15 h at 18°C. The harvested cells were dissolved in 50-70 ml of 50 mM KH 2 PO 4 (pH 7.5) containing 0.3 M KCl, 2.0 mM MgCl 2 , 0.25 mM ThDP, 1.0 mM benzamidine·HCl and 0.5% Triton X-100. Cells were treated with lysozyme (0.60 mg/ml) at 4°C for 20 min. Next, 1000 units of each DNase I, and Micrococcal Nuclease were added and cells were incubated for an additional 20 min at 4°C. Cells were disrupted using a sonic dismembrator and the clarified lysate was loaded onto a Ni-Sepharose High Performance column (GE Healthcare) equilibrated with buffer A containing 50 mM KH 2 PO 4 (pH 7.5), 0.3 M KCl, 2.0 mM MgCl 2 and 0.25 mM ThDP. The protein was eluted with buffer A containing 300 mM imidazole and was concentrated. The buffer was exchanged to 0.1 M Tris·HCl (pH 7.5) containing 0.3 M NH 4 Cl, 2.0 mM MgCl 2 , 0.50 mM ThDP and 1.0 mM benzamidine·HCl using a PD-10 desalting column. Protein was frozen in small aliquots in liquid N 2 and was stored at −80°C. The hE1a amino acid sequence was confirmed by its digestion with pepsin followed by FT-MS detection of the resulting peptides. The peptic digest of hE1a resulted in 85.4% sequence coverage with 80 peptides identified (Table S1 ).
Scheme 1. Mechanism of hE1a assembled with hE2o and hE3 to complex.
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2.4. Overall acitivity of NADH production upon assembly of hE1a with the hE2o and hE3
For complex assembly, the hE1a (0.4 mg, 9.7 μM subunit concentration) in 0.1 M Tris·HCl (pH 7.5), containing 0.3 M NH 4 Cl, 0.5 mM ThDP and 2.0 mM MgCl 2 was mixed with hE2o (0.80 mg, 46 μM subunit concentration) and hE3 (2.0 mg, 100 μM ubunit concentration) components of the OGDHc at a mass ratio (μg: μg:μg) of 1:2:5 for 30 min at 25°C. A 0.01-0.02 ml aliquot of the reaction mixture containing 0.010 mg of hE1a and the corresponding amounts of hE2o and hE3 was withdrawn to start the reaction. The reaction medium contained the following in 1.0 ml: 0.10 M Tris·HCl (pH 7.5), 0.50 mM ThDP, 2.0 mM MgCl 2 , 2.0 mM DTT, 2.5 mM NAD + . The reaction was initiated by addition of OA (1.0 mM) and CoA (0.30 mM) after 1 min of equilibration at 37°C. Steady-state velocities were taken from the linear portion of the progress curve. One unit of activity is defined as the amount of NADH produced (μmol min −1 mg hE1a
). For dependence of the overall activity of NADH production on [2-oxoadipate] , the activities were measured as above using OA in 0.005-0.15 mM range. The data points were fit to a Hill equation (Eq. (1))
2.5. Inhibition of NADH production by succinyl-CoA and by glutaryl-CoA of hE1o and of hE1a both assembled to complex with the same hE2o and hE3
For inhibition of NADH production by succinyl-CoA and by glutarylCoA, the hE1o in 50 mM KH 2 PO 4 (pH 7.5) containing 0.2 M NaCl, 0.50 mM ThDP and 2.0 mM MgCl 2 was mixed with hE2o and hE3 at a mass ratio (μg:μg:μg) of 1:2:5. An aliquot containing 6.7 μg of hE1o and the corresponding amounts of hE2o and hE3 was withdrawn and was added to the reaction assay containing different concentrations of succinyl-CoA (0.038-3.0 mM) or glutaryl-CoA (0.10-2.0 mM). The reaction was initiated by addition of OG (2.0 mM) and CoA (0.20 mM) after 1 min of equilibration at 37°C. The hE1a (0.40 mg) in 0.10 M Tris·HCl (pH 7.5) containing 0.3 M NH 4 Cl was assembled with hE2o and hE3 at a mass ratio (μg:μg:μg) of 1:2:5 for 30 min at 25°C. An aliquot containing 10 μg of hE1a and the corresponding amounts of hE2o and hE3 was withdrawn and was added to the reaction assay containing different concentrations of succinyl-CoA or glutaryl-CoA as above. The reaction was initiated by addition of OA (2 mM) and CoA (0.30 mM) after 1 min of equilibration at 37°C.
hE1a-specific acitivity
The hE1a-specific activity was measured in the reaction medium with the external oxidizing agent 2,6-dichlorophenolindophenol (DCPIP) by monitoring its reduction at 600 nm, similarly to that reported by us earlier for the hE1o [14] .
Reductive acyltransferase reaction in the forward and in the reverse directions
In the forward physiological direction, the E2o lipoyl domain (LDo) (0.150 mM) in 50 mM NH 4 HCO 3 (pH 7.0) was incubated with hE1a (0.2 μM) and ThDP (0.1 mM) at 37°C, as reported by us recently for hE1o [12] . The reaction was initiated by OA (2 mM). An aliquot of 10 μl of the reaction mixture was withdrawn at different times and was quenched into 1 ml of 50% methanol, 0.1% formic acid. Samples were analyzed for relative intensities of the glutarylated and unglutarylated forms of LDo by Fourier transform mass spectrometry (FT-MS). The ratio of the intensity of the glutarylated LDo versus the total intensity (sum of glutarylated and unglutarylated LDo) was plotted against time. The rates of the reaction were calculated from the initial slope determined by a linear fit of the progress curves to initial rate conditions.
In the reverse direction, the LDo (0.100 mM) in 50 mM NH 4 HCO 3 (pH 7.0) was incubated with 0.1 mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and 0.1 μM E2o catalytic domain at 37°C. The reaction was initiated by addition of 0.70 mM glutaryl-CoA. Samples were analyzed for relative intensities of the dihydro-LDo and glutaryldihydro-LDo by FT-MS. The ratio of the intensity of the glutaryldihydro-LDo versus the total intensity (sum of dihydro-LDo and glutaryldihydro-LDo) was plotted against time. Once more, the rates of the reaction were calculated from the initial slope determined by a linear fit of the progress curves to initial rate conditions.
Measurement of the rate of H 2 O 2 production
The rate of H 2 O 2 production by hE1a and by hE1a assembled into complex with hE2o and hE3 was measured using a fluorescent Amplex UltraRed reagent, in an assay reported earlier in the literature [12, [19] [20] [21] [22] . The reaction medium in 2.5 ml contained: 5 mM HEPES, 5 mM KH 2 PO 4 , (pH 7.0), 0.15 M NaCl, 2.5 mM MgCl 2 , 0.25 mM ThDP, 1.0 mM EDTA, 50 μM Amplex UltraRed, 5 units/ml of horseradish peroxidase (HRP), 25 units /ml of superoxide dismutase (SOD) and 0.1 mg of hE1a at 37°C. For hE1a assembly with hE2o and hE3, hE1a (32.3 μM subunits) was mixed with hE2o (32.3 μM subunits) and hE3 (32.3 μM subunits) in 0.1 M Tris·HCl (pH 7.5) containing 0.30 M NH 4 Cl, 0.5 mM ThDP and 2.0 mM MgCl 2 . Time-dependent H 2 O 2 production was measured on a Varian Cary Eclipse fluorescence spectrophotometer in the kinetic mode with an excitation wavelength of 560 nm and emission wavelength of 590 nm. The reaction was initiated by OA (2 mM) or OG (5 mM) after 2-3 min recording of background due to the spontaneous oxidation of Amplex UltraRed. The amount of H 2 O 2 produced was calculated from a calibration curve that was generated with known concentrations of H 2 O 2 using a reaction assay similar to that used in the experiment. The slope due to background oxidation of Amplex UltraRed was subtracted from all experimental curves. The activity is defined as the amount of H 2 O 2 produced taking into account that Amplex UltraRed reacts with HRP-H 2 O 2 at a 1:1 stoichiometry (nmol min −1 mg hE1a
Circular dichroism spectroscopy
CD spectra of the (S)-2-hydroxy-3-oxoheptanedioic acid product formed by hE1o (2.0 mg/ml) from OA (2 mM) and glyoxylate (10 mM) at 4°C in 50 mM KH 2 PO 4 , 50 mM Tris·HCl (pH 7.5) containing 0.20 mM ThDP and 2.0 mM MgCl 2 for 15 h, were recorded on a Chirascan CD spectrometer (Applied Photopysics, Leatherhead, UK) in 1-cm path length cell in the near-UV (280-450 nm) wavelength region. Time-dependent synthesis of (S)−2-hydroxy-3-oxoheptanedioic acid and (R)−2-hydroxy-3-oxohexanedioic acid by hE1a from OA or OG as substrate and glyoxylate as an acceptor were monitored by CD continuously at 280 nm in the kinetic mode. A typical reaction mixture in a 2.4 ml cuvette contained: 5 mM HEPES and 5 mM KH 2 PO 4 (pH 7.0), 0.15 M NaCl, 0.15 mM ThDP, 2.5 mM MgCl 2 , 2.0 mM OA or 10 mM OG and 10 mM glyoxylate. The reaction was initiated by hE1a (0.1 mg/ml) and was monitored for 500 s at 37°C. Lineweaver-Burk plots were obtained by varying OA (0-14.5 mM) or OG (0-25 mM) in the presence of fixed concentration of glyoxylate (10 mM). Steady state velocities were calculated from the linear region of the progress curves and were fit to a modified Hill equation (Eq. (2))
Electron paramagnetic resonance spectroscopy
For hE1a sample preparation, the following protocol was used: hE1a (43 mg/ml, 0.418 mM hE1a active centers) in 0.3 ml of 0.1 M Tris·HCl (pH 7.5) containing 0.30 M NH 4 Cl, 0.5 mM ThDP, 2.0 mM MgCl 2 , 1.0 mM benzamidine·HCl and 1 mM DTT was mixed with 10 mM OA or 10 mM OG at room temperature. The mixture was immediately transferred into an EPR tube and was flash-frozen in liquid nitrogen after approximately 30-40 s of incubation of all components.
X-band (9 GHz) EPR measurements were made using a Varian E-112 spectrometer equipped with a TE 102 cavity and interfaced to a PC using custom written software. The sample temperature was held at 77 K using an immersion finger Dewar. Spectrometer parameters used to acquire the spectra are as follows: modulation amplitude: 1×10 G; microwave power, 0.20 mW; receiver gain, 3.2×10 4 ; microwave frequency, 9.1 GHz; scan time 2.0 min; time constant, 1 s; number of scans 4. The field was calibrated using a standard sample of manganese doped in MgO [23] .
3. Results and discussion 3.1. Evidence for NADH production from 2-oxoadipate by hE1a assembled with hE2o and hE3 components of the OGDHc
We first sought evidence for communication/interaction of hE1a with hE2o, if, as hypothesized, the function of hE1a is similar to that of hE1o of OGDHc. With the availability of hE1a, hE2o and hE3 components in our group, we wished to address whether hE1a catalyzes the conversion of OA and NAD + to glutaryl-CoA and NADH according to the overall reaction (Eq. (3)) (see also Scheme 1). 
The progress curves of NADH formation at different concentrations of OA are presented in Fig. 1 ) (Table 1) . Also, the value of K m,OA of 0.015 mM according to the overall NADH assay was approximately 17-fold lower than that for OG (K m,OG = 0.25 mM), both steady state constants, indicating that hE1a has a preference for OA over OG. The pH-dependence of the overall hE1a activity with OA displayed maximum activity at pH 6.7-7.2 with an apparent pK a =7.99 ± 0.05 on the alkaline side of the curve (data not shown).
3.2. Evidence for reductive glutarylation of hE2o by hE1a and OA, and for subsequent glutaryl transfer to CoA catalyzed by hE2o
Direct evidence for communication between hE1a and hE2o, and between two sites involved in acyl transfer on hE2o, was obtained via the reductive acyltransferase reaction in the forward physiological, and acyl transfer within hE2o in the reverse direction. In the forward physiological direction, the enamine intermediate formed on hE1a after decarboxylation of OA reductively glutarylates the lipoamide groups on hE2o with the formation of S8-glutaryldihydrolipoyl-E2o (see Scheme 1, left hand). Reductive glutarylation of hE2o could be analyzed by FT-MS in a model reaction using independently expressed lipoyl domain replacing an entire hE2o, which is a highly segmented protein comprising, from the N-terminal end, a single lipoyl domain (LDo), a peripheral subunit-binding domain (PSBD), and an acyltransferase or catalytic domain (CDo). On addition of OA to a pre-incubated mixture of hE1a and LDo, two major forms of the LDo were detected by FT-MS: unglutarylated LDo with mass of 11,247.3 Da and glutarylated LDo with mass of 11, 363.3 Da (the mass was increased by 116 Da on glutarylation). The fraction of reductively glutarylated LDo versus total LDo (glutarylated plus un-glutarylated) when plotted against incubation time enabled calculation of k glutaryl of 7.6 ± 0.89 s −1 (an average from three independent experiments) (Fig. 2) . When compared with the k cat of 6.0 ± 0.07 s −1 determined in the overall NADH assay (hE1a assembled to complex with hE2o and hE3) (see Table 1 ), it became evident that transfer of the glutaryl group from hE1a to hE2o (reductive glutarylation of hE2o by hE1a and OA) could be a rate limiting step. In the reverse direction, the dihydro-LDo [LDo reduced by tris (2-carboxyethyl)phosphine), TCEP] and hE2o catalytic domain, both individually expressed, were reacted with glutaryl-CoA according to Eq. (4). 
Again, measurement of the masses of dihydro-LDo and glutaryldihydro-LDo by FT-MS was used to quantify the rate of glutaryl transfer from glutaryl-CoA to dihydro-LDo in the reaction catalyzed by the CDo (Fig. 2) . A rate constant of 9.7 s −1 calculated from a linear fit to the initial rate of glutaryldihydro-LDo formation is similar to k glutaryl of 7.6 ± 0.89 s −1 in the forward physiological direction, and k cat of 6.0 ± 0.07 s −1 for NADH formation in the overall assay (Table 1) . It could be concluded that the hE2o catalytic domain catalyzes the reaction in Eq. (4) in both directions and this reaction is expected to have an equilibrium constant near unity, hence the kinetic barrier should be similar in both directions. It also needs to be mentioned that an S 0.5, LDo of 8.9 μM was estimated for hE1a in the overall NADH assay where hE2o was replaced by its LDo and hE2o catalytic domain expressed independently, with no covalent linkage between them, and in the absence of PSBD. This value was similar to the S 0.5, LDo of 7.9 ± 1.3 μM estimated for hE1o in a similar experiment, indicating that hE1a behaves similarly to hE1o on interaction with the hE2o lipoyl domain (Supporting information Fig. S1 ). In the absence of an E2o component, an artificial two-electron acceptor 2,6-dichlorophenol-indophenol (DCPIP) can be used to study the oxidation step of hE1a with OA or OG in Scheme 1 [24] . DCPIP oxidizes the central enamine intermediate with formation of the reduced form of DCPIP that could be detected at λ max = 600 nm, providing a useful tool to confirm that decarboxylation takes place. of OA in the hE1a-specific assay were comparable to that determined with OA in the overall assay, these values were about 43-fold (k cat ) and 187-fold lower (k cat /K m,OG ) with OG as substrate ( Table 1 ). The data once more confirmed that hE1a has a preference for OA over OG.
The hE1a catalyzes formation of carboligation products from OA and glyoxylate affirming that hE1a is a 2-oxo acid decarboxylase
In the absence of hE2o and hE3, the enamine intermediate formed on decarboxylation of OA on hE1a has an alternative pathway called carboligation, where the enamine adds to an aldehyde acceptor to form chiral α-ketol carboligation products. Such a reaction was earlier reported for Mycobacterium tuberculosis E1o-like protein [25] , and for hE1o using either OG or OA as substrates [12] . Since no E2o component specific for hE1a could be identified so far, this alternative carboligase option needed to be considered.
The newly formed α-ketol carboligation products are chiral and could be detected by circular dicroism (CD) spectroscopy. A positive CD band with λ max at 280 nm was detected in the near-UV spectra of hE1a acting on OA as a substrate donor and glyoxylate as an acceptor. By analogy with the carboligation reaction of hE1o, the observed CD 280 band was assigned to (S)−2-hydroxy-3-oxoheptanedioic acid (Fig. 3,  top) . The progress curves of (S)−2-hydroxy-3-oxoheptanedioic acid formation demonstrated dependence on concentration of OA in the presence of fixed glyoxylate concentration (10 mM Fig. S2 ). In view of these results, the carboligase activity of hE1a should be considered as a side-reaction, and the decarboxylation of OA with the subsequent glutarylation of hE2o according to the accepted mechanism for 2-oxo acid dehydrogenase complexes, is the predominant path (see Scheme 1).
The hE1a forms the ThDP-enamine radical from OA according to electron paramagnetic resonance (EPR) detection in the oxidative half reaction
One-electron oxidation of the enamine intermediate by molecular O 2 is commonly observed as a side reaction in ThDP enzymes, while it is the principal pathway on several others, such as on pyruvate:ferredoxin oxidoreductase [26, 27] and on pyruvate oxidase [28] . Earlier, we reported that hE1o by itself and when assembled to OGDHc with hE2o and hE3, could generate the ThDP-enamine radical from one-electron oxidation of the enamine, derived from both OG and OA, and with a half-life of approximately 1 min (see Scheme 1, right hand) [12] . The concentration of the radical species on hE1o was approximately threetimes lower with OA than with OG as detected by EPR [12, 14] . These 
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studies were extended to hE1a by recording X-band EPR spectra for the aerobic reaction of hE1a with 10 mM OA. As shown in Fig. 4 , the Xband EPR spectra displayed a line shape similar to that detected in the hE1o-ThDP-OG and in the hE1o-ThDP-OA reactions, consistent with the presence of the ThDP-enamine radical species [12, 14] . The concentration of ThDP-enamine radical species in the hE1a active centers was estimated as 0.2 μM (0.1% occupancy) and 0.5 μM (0.12% occupancy) in two independent experiments when derived from OA, but less than 0.1 μM from OG. Earlier, we reported concentration of 0.9 μM (0.2% occupancy) in the hE1o-ThDP-OG reaction and of 1.3 μM (0.59% occupancy) in the hOGDHc-ThDP-OG reaction [14] . These data demonstrate formation of the ThDP-enamine radical species on hE1a from decarboxylation of OA, and in a lesser amount from OG. It is known that hOGDHc has the highest capacity of H 2 O 2 generation within the NADH/NAD + isopotential group in mammalian mitochondria, which has been attributed to the flavin-containing E3 component [13, [29] [30] [31] [32] [33] [34] . Recently, it was reported by our groups that independently of hE3, hE1o on its own, and hE1o assembled into OGDHc, could produce superoxide and H 2 O 2 from decarboxylation of OG, as well as of OA in the forward physiological direction [12, 14, 33] . It was concluded that the major source of the superoxide and H 2 O 2 produced by hE1o is the result of the O 2 reduction half-reaction accompanying the one-electron oxidation of the enamine intermediate to the ThDP-enamine radical (detected by EPR) (Scheme 1) [12, 14] . Others have reported H 2 O 2 production from OA by rat skeletal muscle mitochondria, and it was once more attributed to the E3 component of a putative mitochondrial 2-oxoadipate dehydrogenase complex [13, 34] . The following studies were performed to assess the contribution of hE1a to superoxide and H 2 O 2 production from both OA and OG ( ), or of hE1a assembled to complex with hE2o and hE3 (0.083 ± 0.025 nmol min −1 mg hE1a
) were similar, indicating that the hE1a component is responsible for H 2 O 2 production from both substrates. The studies above also indicate that hE1a is at least 60-times more efficient in H 2 O 2 production from OA than from OG.
In view of these striking differences in H 2 O 2 activities determined for hE1a and hE1o using OA, the following controls were performed for the Amplex UltraRed fluorescence assay, which support our findings above: (a) No H 2 O 2 production was detected in the absence of OA in the reaction assay, as evident from a small background slope detected in the S3 ); (c) The H 2 O 2 production by hE1a was sensitive to inhibition by α-keto-β-methyl-n-valeric acid (KMV), a structural analogue of OG, known as a specific competitive inhibitor of OGDHc [35, 36] . Unexpectedly, both the NADH and H 2 O 2 activities of hE1a were inhibited by KMV and the K i, KMV vis-à-vis hE1a was much lower than that reported by us recently for hOGDHc [12] . In the NADH assay a K i,KMV of 5.7 μM was determined for hE1a assembled to complex with hE2o and hE3, compared to K i,KMV of 730 μM reported for hOGDHc assembled from hE1o and the same hE2o and hE3 components [12] . Similarly, in the H 2 O 2 assay the K i, KMV was 0.127 mM (hE1a + hE2o +hE3) and 1.12 mM (hE1o + hE2o + hE3) (SI Fig. S3 for hE1a and ref. [12] for hOGDHc). These results contribute to our understanding of the antioxidant function of KMV related to oxidative stress (scavenger of free radicals) that occurs in neurodegenerative diseases.
3.7. The hE1a and hE1o when assembled to complex with the same hE2o and hE3 components experience strikingly different regulation 3.7.1. Effect of succinyl-CoA and glutaryl-CoA on NADH production by hE1o and hE1a assembled with hE2o and hE3
The reversible post-translational modification of proteins by succinylation and glutarylation, and an identification of the sources of succinyl and glutaryl groups is a widely investigated current issue, as it may play a role in neurodegenerative diseases [37] [38] [39] [40] [41] . Earlier, it was reported that OGDHc can regulate the post-translational modification of mitochondrial proteins by succinylation and that its E2o component can provide succinyl groups for enzymatic succinylation [39] . A diminished OGDHc activity was reported in multiple neurodegenerative diseases [42] [43] [44] [45] [46] [47] . No such information is available for hE1a. To gain more insight into the function of this protein, we first studied the effect of succinyl-CoA and glutaryl-CoA on NADH production by both hE1o and hE1a assembled to complex with the same hE2o and hE3 components (Fig. 6 ). The overall NADH activity of hE1o was significantly reduced by both succinyl-CoA and glutaryl-CoA with calculated values However, the overall NADH activity of hE1a could not be inhibited to 50% by succinyl-CoA even at the highest concentration (4 mM) tested.
Corresponding inhibition by glutaryl-CoA, gave a [I] 0.5, glutaryl-CoA of 2.33 mM, approximately 5-times higher than that for hE1o. The hE1a is also inhibited at a much slower rate compared to hE1o, indicating that it is indeed the first component of the corresponding complexes that is subject to regulation rather than hE2o and hE3. The data also suggest that hE1a could provide glutaryl-CoA groups for post-translational modification of proteins and for regulation of OGDHc activity in mitochondria.
3.7.2. Inhibition by phosphonate analogues of 2-oxoglutarate and 2-oxoadipate Phosphonate analogues behave as tight-binding inhibitors of ThDPdependent enzymes by mimicking their substrates [48] [49] [50] [51] [52] [53] . The covalent adduct of the inhibitor with ThDP in the active centers of ThDPdependent enzymes resembles the first pre-decarboxylation intermediate and could be detected by circular dicroism spectroscopy [50] [51] [52] . It has been reported earlier that succinyl phosphonate (SP 2-) and its phosphonoethyl ester which are analogues of OG, can effectively inhibit the OGDHc activity of the isolated mammalian complex and in fibroblasts [49] . In the current study, we have analyzed the effect of the following phosphonate analogues on hE1a and on hE1o assembled to complex with hE2o and E3: succinylphosphonate and succinylphosphonate methyl ester (SPME -), analogues of OG, and glutarylphosphonate monoethyl ester (GPEE -), an analogue of 2-oxoadipate. The overall activity of NADH production by the two enzyme systems was measured in the presence of phosphonate analogues and the % inhibition achieved was plotted versus concentration of inhibitor (Fig. 7) . From these studies, it is evident that succinylphosphonate was a more efficient inhibitor of hE1o than of hE1a. The value of K i,SP 2-of 0.38 mM (hE1o) was in the range of K m,OG of 0.15 mM [14] while with hE1a the value of [I] 0.5 of 7 mM was much higher than values of K m,OA = 0.015 mM and K m,OG = 0.25 mM ( Table 1 ), suggesting that succinylphosphonate is a poor inhibitor for hE1a (Fig. 7) . The inhibitory effect of succinylphosphonate methyl ester was also demonstrated with the values of K i,SPME-of 0.41 mM (hE1a) and of 0.65 mM (hE1o) (data not shown). Again, it is a poor inhibitor of hE1a using OA as a substrate. With glutarylphosphonate monoethyl ester tested on hE1a, only 45% of inhibition was reached at 25 mM inhibitor concentration (data not shown).
Conclusions
The important conclusion from our studies in this paper combined with results reported by us earlier [12, 14, 33] , is that hE1a and hE1o assembled with the same hE2o and hE3 components into the corresponding multienzyme complexes (OGDHc and OADHc), are not functionally redundant.
1. While both OG and OA could be oxidized by hE1a, this enzyme displays an approximately 49-fold preference in catalytic efficiency for OA over OG, indicating that hE1a participates in the OADHc (see Table 3 and Scheme 2 for comparison between hE1a and hE1o by using both substrates). These studies represent the first experimental evidence for the 2-oxoadipate dehydrogenase complex, which is involved in oxidation of OA on the final degradative pathway of Llysine, L-hydroxylysine and L-tryptophan in mammalian mitochondria. 2. Similar to hE1o, the hE1a forms the ThDP-enamine radical from OA according to EPR detection in the oxidative half reaction and could produce superoxide and H 2 O 2 from decarboxylation of OA in the forward physiological direction. These studies and those reported by us and others earlier suggest that superoxide and H 2 O 2 generation could be a common feature of all ThDP-dependent dehydrogenases [12, 14, 33, 54] . 3. The hE1o and hE1a experience strikingly different regulation by succinyl-CoA and glutaryl-CoA products and by phosphonate analogues of their substrates. 4. The biological significance of OADHc is not limited to oxidation of 2-oxoadipate: i) OADHc could be a source of glutaryl groups for reversible posttranslational modification of proteins by glutarylation, a current issue of wide interest related to neurodegenerative diseases; ii) the pharmacological inhibition of hE1a could be a promising strategy to treat glutaric aciduria type I, especially in view of a difference in regulation of hE1o and hE1a that was elucidated in these studies. iii) Both, hE1a and hE1o could contribute to oxidative stress in mitochondria related to pathologies associated with neurodegenerative disorders.
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Table 3
Comparison of the steady-state kinetic parameters for NADH production determined for hE1o and for hE1a, both assembled with hE2o and hE3 components.
E1 source + hE2o +hE3
Overall activity, OA a (units·mg hE1 
